People · Operator
Named in public records as an officer, director or promoter · active 2016–2022 · Pharmaceuticals, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NeuroRx, Inc. | — | Pharmaceuticals | Series A | $6.7M | $140.7M | 2016 |
| Engiven, Inc. | — | Other Technology | Seed | $2.9M | $13.1M | 2018 |
James Lawrence at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Lawrence on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Chaim Hurvitz | 1 | 6 |
| Matthew Hayes | 1 | 3 |
| Jonathan Javitt | 1 | 3 |
| Brandon Murphy | 1 | 1 |
| Wallace Tsuha | 1 | 1 |
| David Pelling | 1 | 1 |
| Sherry Glied | 1 | 1 |
| Daniel Javitt | 1 | 1 |
| Justin Greene | 1 | 1 |
| Hui Ly | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.